{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:15:52Z","timestamp":1779200152252,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s13555-022-00744-8","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T17:02:51Z","timestamp":1654534971000},"page":"1447-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5879-9060","authenticated-orcid":false,"given":"Lida","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-199X","authenticated-orcid":false,"given":"Akiko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-2305","authenticated-orcid":false,"given":"Cheryl","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Giannelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-089X","authenticated-orcid":false,"given":"Tomohide","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-187X","authenticated-orcid":false,"given":"Christa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-4261","authenticated-orcid":false,"given":"Taizo","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI, et\u00a0al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. https:\/\/doi.org\/10.1038\/nrdp.2015.16.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"744_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/ijdvl.IJDVL_1021_16","volume":"84","author":"E Koshy","year":"2018","unstructured":"Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018;84(3):251\u201362.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"744_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40261-017-0581-5","volume":"38","author":"A Mizukami","year":"2018","unstructured":"Mizukami A, Sato K, Adachi K, et\u00a0al. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018;38(1):29\u201337.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"744_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40801-017-0119-4","volume":"4","author":"H Nakamura","year":"2017","unstructured":"Nakamura H, Mizukami A, Adachi K, et\u00a0al. Economic burden of herpes zoster and post-herpetic neuralgia in adults 60 Years of age or older: results from a prospective, physician practice-based cohort study in Kushiro, Japan. Drugs Real World Outcomes. 2017;4(4):187\u201398.","journal-title":"Drugs Real World Outcomes"},{"issue":"7","key":"744_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1086\/651199","volume":"201","author":"A Weinberg","year":"2010","unstructured":"Weinberg A, Lazar AA, Zerbe GO, et\u00a0al. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis. 2010;201(7):1024\u201330.","journal-title":"J Infect Dis"},{"issue":"1","key":"744_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12877-017-0420-9","volume":"17","author":"L Varghese","year":"2017","unstructured":"Varghese L, Standaert B, Olivieri A, Curran D. The temporal impact of aging on the burden of herpes zoster. BMC Geriatr. 2017;17(1):30.","journal-title":"BMC Geriatr"},{"key":"744_CR7","unstructured":"Cabinet Office Government of Japan. White paper on ageing society 2020. https:\/\/www8.cao.go.jp\/kourei\/whitepaper\/w-2020\/html\/zenbun\/index.html. Accessed Jan 2022."},{"key":"744_CR8","unstructured":"Japan Pharmaceuticals and Medical Devices Agency. Package insert for varicella vaccine live attenuated \"Biken\". https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/630144_631340ED1022_1_24. Accessed Jan 2022."},{"issue":"24","key":"744_CR9","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1016\/j.vaccine.2017.04.046","volume":"35","author":"SL Hoshi","year":"2017","unstructured":"Hoshi SL, Kondo M, Okubo I. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine. 2017;35(24):3264\u201371.","journal-title":"Vaccine"},{"issue":"22","key":"744_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, et\u00a0al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"11","key":"744_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, et\u00a0al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"744_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s13555-019-0291-4","volume":"9","author":"M Shiragami","year":"2019","unstructured":"Shiragami M, Mizukami A, Kaise T, et\u00a0al. Cost-effectiveness of the adjuvant recombinant zoster vaccine in Japanese adults aged 65 years and older. Dermatol Ther (Heidelb). 2019;9(2):281\u201397.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"27","key":"744_CR13","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.vaccine.2019.05.006","volume":"37","author":"SL Hoshi","year":"2019","unstructured":"Hoshi SL, Seposo X, Shono A, Okubo I, Kondo M. Cost-effectiveness of recombinant zoster vaccine (RZV) and varicella vaccine live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan. Vaccine. 2019;37(27):3588\u201397.","journal-title":"Vaccine"},{"key":"744_CR14","unstructured":"Shibahara H. Cost-effectiveness analysis of herpes zoster vaccine for the elderly in Japan. In: The 16th annual conference of Japan Health Economics Association (JHEA); Virtual, 2019. Presentation M-5."},{"key":"744_CR15","unstructured":"Japan Pharmaceuticals and Medical Devices Agency. Package insert for recombinant zoster vaccine Shingrix. https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/340278_631341BE1028_2_04. Accessed Jan 2022."},{"issue":"33","key":"744_CR16","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1016\/j.vaccine.2018.07.005","volume":"36","author":"D Curran","year":"2018","unstructured":"Curran D, Patterson B, Varghese L, et\u00a0al. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States. Vaccine. 2018;36(33):5037\u201345.","journal-title":"Vaccine"},{"issue":"1","key":"744_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/21645515.2018.1509645","volume":"15","author":"D Van Oorschot","year":"2019","unstructured":"Van Oorschot D, Anastassopoulou A, Poulsen Nautrup B, et\u00a0al. Cost-effectiveness of the recombinant zoster vaccine in the German population aged \u2265\u00a060 years old. Hum Vaccin Immunother. 2019;15(1):34\u201344.","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"744_CR18","first-page":"1226","volume":"149","author":"K Iwatsuki","year":"2020","unstructured":"Iwatsuki K. Herpes Zoster Vaccine. J Jpn Med Assoc. 2020;149(7):1226.","journal-title":"J Jpn Med Assoc"},{"issue":"8","key":"744_CR19","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/cid\/ciab629","volume":"74","author":"C Boutry","year":"2021","unstructured":"Boutry C, Hastie A, Diez-Domingo J, et\u00a0al. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase III clinical trials (ZOE-50 and ZOE-70). Clin Infect Dis. 2021;74(8):1459\u201367.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"744_CR20","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1080\/21645515.2021.2002085","volume":"17","author":"D Curran","year":"2021","unstructured":"Curran D, Van Oorschot D, Matthews S, et\u00a0al. Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Hum Vaccin Immunother. 2021;17(12):5296\u2013303.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"744_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40273-012-0020-7","volume":"31","author":"TD Szucs","year":"2013","unstructured":"Szucs TD, Pfeil AM. A systematic review of the cost effectiveness of herpes zoster vaccination. Pharmacoeconomics. 2013;31(2):125\u201336.","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"744_CR22","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1080\/21645515.2017.1345399","volume":"13","author":"D Curran","year":"2017","unstructured":"Curran D, Van Oorschot D, Varghese L, et\u00a0al. Assessment of the potential public health impact of herpes zoster vaccination in Germany. Hum Vaccin Immunother. 2017;13(10):2213\u201321.","journal-title":"Hum Vaccin Immunother"},{"key":"744_CR23","unstructured":"Ikeda S. Guideline for study on the economic evaluation of vaccination. MHLW grants study. https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000184902_1.pdf. Accessed Jan 2022."},{"key":"744_CR24","unstructured":"Ministry of Health, Labour and Welfare (MHLW). Implementation guideline for National Immunization Program. https:\/\/www.mhlw.go.jp\/content\/000757429.pdf. Accessed Jan 2022."},{"issue":"4","key":"744_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hec.1481","volume":"19","author":"T Shiroiwa","year":"2010","unstructured":"Shiroiwa T, Sung YK, Fukuda T, et\u00a0al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422\u201337.","journal-title":"Health Econ"},{"issue":"10","key":"744_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/13696998.2019.1639186","volume":"22","author":"A Igarashi","year":"2019","unstructured":"Igarashi A, Goto R, Yoneyama-Hirozane M. Willingness to pay for QALY: perspectives and contexts in Japan. J Med Econ. 2019;22(10):1041\u20136.","journal-title":"J Med Econ"},{"issue":"9","key":"744_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1080\/14760584.2021.1952869","volume":"20","author":"A Igarashi","year":"2021","unstructured":"Igarashi A, Hirose E, Kobayashi Y, Yonemoto N, Lee B. Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan. Expert Rev Vaccines. 2021;20(9):1153\u201365.","journal-title":"Expert Rev Vaccines"},{"key":"744_CR28","unstructured":"Statistics Bureau (Ministry of Internal Affairs and Communications). E-Stat: Portal Site of Official Statistics of Japan. https:\/\/www.e-stat.go.jp\/. Accessed Aug 2021."},{"issue":"10","key":"744_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2188\/jea.JE20140210","volume":"25","author":"Y Takao","year":"2015","unstructured":"Takao Y, Miyazaki Y, Okeda M, et\u00a0al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25(10):617\u201325.","journal-title":"J Epidemiol"},{"issue":"1","key":"744_CR30","doi-asserted-by":"publisher","first-page":"ofx007","DOI":"10.1093\/ofid\/ofx007","volume":"4","author":"K Shiraki","year":"2017","unstructured":"Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017;4(1):ofx007. https:\/\/doi.org\/10.1093\/ofid\/ofx007.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"744_CR31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jiz652","volume":"222","author":"HF Tseng","year":"2020","unstructured":"Tseng HF, Bruxvoort K, Ackerson B, et\u00a0al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults \u2265\u00a050 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. 2020;222(5):798\u2013806.","journal-title":"J Infect Dis"},{"issue":"2","key":"744_CR32","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e1","volume":"34","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Lee CN, Lee MS, et\u00a0al. Recurrence rate of herpes zoster and its risk factors: a population-based cohort study. J Korean Med Sci. 2018;34(2): e1. https:\/\/doi.org\/10.3346\/jkms.2019.34.e1.","journal-title":"J Korean Med Sci"},{"key":"744_CR33","unstructured":"Ministry of Health, Labour and Welfare (MHLW). Vaccination information. http:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html. Accessed Jan 2022."},{"key":"744_CR34","unstructured":"Ministry of Health, Labour and Welfare (MHLW). About medical fee revision in 2020. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000188411_00027.html. Accessed Jan 2022."},{"key":"744_CR35","unstructured":"Ministry of Health, Labour and Welfare (MHLW). About listing in the National Health Insurance price list and generics in 2020. https:\/\/www.mhlw.go.jp\/topics\/2020\/04\/tp20200401-01.html. Accessed Jan 2022."},{"key":"744_CR36","unstructured":"Ministry of Health, Labour and Welfare (MHLW). About medical fee revision. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000106602.html. Accessed Jan 2022."},{"key":"744_CR37","unstructured":"Shiroiwa T. Examination of how to present the results of cost-effectiveness evaluation of vaccines-cost-effectiveness analysis of vaccination against rotavirus. MHLW Research Grant (Emerging\/Reemerging Infectious Diseases and Vaccination Policy Promotion Research Project). 2016."},{"issue":"4","key":"744_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/1346-8138.13639","volume":"44","author":"K Sato","year":"2017","unstructured":"Sato K, Adachi K, Nakamura H, et\u00a0al. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: results from an observational, prospective, physician practice-based cohort study. J Dermatol. 2017;44(4):414\u201322.","journal-title":"J Dermatol"},{"issue":"8","key":"744_CR39","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1080\/21645515.2021.1879579","volume":"17","author":"BJ Patterson","year":"2021","unstructured":"Patterson BJ, Chen C-C, Mcguiness CB, et\u00a0al. Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019. Hum Vaccin Immunother. 2021;17(8):2482\u20137.","journal-title":"Hum Vaccin Immunother."},{"issue":"6","key":"744_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/M18-2347","volume":"170","author":"LA Prosser","year":"2019","unstructured":"Prosser LA, Harpaz R, Rose AM, et\u00a0al. A cost-effectiveness analysis of vaccination for prevention of herpes zoster and related complications: input for national recommendations. Ann Intern Med. 2019;170(6):380\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"744_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jamainternmed.2017.7431","volume":"178","author":"P Le","year":"2018","unstructured":"Le P, Rothberg MB. Cost-effectiveness of the adjuvanted herpes zoster subunit vaccine in older adults. JAMA Intern Med. 2018;178(2):248\u201358.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"744_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13555-018-0236-3","volume":"8","author":"D Watanabe","year":"2018","unstructured":"Watanabe D, Mizukami A, Holl K, et\u00a0al. The potential public health impact of herpes zoster vaccination of people aged \u2265\u00a050 years in Japan: results of a Markov model analysis. Dermatol Ther (Heidelb). 2018;8(2):269\u201384.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"744_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6): e004833.","journal-title":"BMJ Open"},{"issue":"7","key":"744_CR44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/1346-8138.13784","volume":"44","author":"M Honda","year":"2017","unstructured":"Honda M, Murata T, Ebata N, Fujii K, Ogawa S. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: analysis of Japanese claims data provided by Japan Medical Data Center. J Dermatol. 2017;44(7):767\u201373.","journal-title":"J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00744-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:47:01Z","timestamp":1655783221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00744-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00744-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}